Published: Guidance, quality standards and advice
Showing 21 to 22 of 22
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma | TA540 | ||
| Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma in people 3 years and over | TA967 |